[Ghrelin in the treatment of cardiovascular disease].
Nagaya
Noritoshi
N
Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute.
Kangawa
Kenji
K
D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D002320:Cardiovascular Physiological Phenomena / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D004734:Energy Metabolism / Q000187:drug effects; D054439:Ghrelin; D013006:Growth Hormone / Q000502:physiology; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D036361:Peptide Hormones / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use*; D013564:Sympathetic Nervous System / Q000502:physiology
D054439:Ghrelin; D036361:Peptide Hormones; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone